Template:Company
What They Do
Scalable stem cell manufacturing to lower global stem cell costs by 90%.[1]
Funding
Valuation: ~€30-50M ($12M raised)
$12 million (October 2025). Earlier rounds included €10.3 million.[2]
Key Relationship
Bryan Johnson's go-to stem cell provider.[3]
See Also
- ↑ Sifted (Oct 2025): "Bryan Johnson's go-to stem cell startup Cellcolabs lands $12m for worldwide rollout"
- ↑ EU-Startups (Oct 27, 2025): "€10.3 million boost for Sweden's Cellcolabs to lower global stem cell costs by 90%"
- ↑ Sifted, Oct 2025